Question 1

Am I eligible to participate in this study based on my previous involvement in the REGARD trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial clinical trial (NCT01034579). Contact the study team or your healthcare provider for specific answers.

Question 2

What specific information will the blood sample provide about my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial clinical trial (NCT01034579). Contact the study team or your healthcare provider for specific answers.

Question 3

How will the results of this study impact my current MS treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial clinical trial (NCT01034579). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the potential risks or benefits of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial clinical trial (NCT01034579). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my privacy be protected when my blood sample is analyzed?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial clinical trial (NCT01034579). Contact the study team or your healthcare provider for specific answers.

What this study is about